ABBV

Abbvie Inc.
Pharmaceuticals

Cash & Equivalents

$5.23B
As of 2025-12-31
Current Price: $207.94 (as of 2026-04-12)

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $5.23B
Total Obligations: -$108.72B
$-103.49B
Per share: $-58.50
Period: 2025-12-31

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $5.23B
AR: $12.59B
Total Obligations: -$108.72B
$-90.90B
Per share: $-51.38
Period: 2025-12-31

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $5.23B
AR: $12.59B
Inventory: $4.95B
Total Obligations: -$108.72B
$-85.95B
Per share: $-48.59
Period: 2025-12-31

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-103.49B$-58.50
Liquid Liquidation Value$-90.90B$-51.38
Operating Liquidation Value$-85.95B$-48.59

Key Components (as of 2025-12-31)

Cash & Equivalents$5.23B
Accounts Receivable$12.59B
Inventory$4.95B
Current Liabilities$43.29B
Long-term Debt$64.50B
Op. Lease Liability$883.00M
Finance Lease$41.00M
Shares Outstanding1.77B

Explore all 261 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2025-12-31 $5.23B $12.59B $4.95B $3.59B $43.29B $64.50B $883.00M $41.00M
2025-09-30 $5.63B $12.77B $4.94B N/A $39.39B $64.95B N/A N/A
2025-06-30 $6.47B $12.64B $4.96B N/A $39.77B $64.92B N/A N/A
2025-03-31 $5.17B $12.48B $4.53B N/A $36.40B $68.30B N/A N/A
2024-12-31 $5.52B $10.92B $4.18B $2.94B $38.75B $66.84B $875.00M $40.00M
2024-09-30 $7.26B $11.47B $4.45B N/A $43.06B $71.08B N/A N/A
2024-06-30 $13.13B $11.72B $4.22B N/A $41.91B $70.63B N/A N/A
2024-03-31 $18.07B $11.95B $4.25B N/A $41.52B $74.00B N/A N/A

SEC Filings

PeriodFormFiledLink
2025-12-31 10-K 2026-02-20 View
2025-09-30 10-Q 2025-11-04 View
2025-06-30 10-Q 2025-08-04 View
2025-03-31 10-Q 2025-05-09 View
2024-12-31 10-K 2025-02-14 View
2024-09-30 10-Q 2024-11-04 View
2024-06-30 10-Q 2024-08-07 View
2024-03-31 10-Q 2024-05-03 View